Great opportunity, but brace yourself for a rough ride - Recensione dipendente - Clinical Development presso argenx

3,0
9 dic 2022
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Successful drug with great promise for future indications. Excellent science and stellar early commercial success. My colleagues and fellow support functions. Many functional heads on the clinical side of the company, some new senior management. Salary growth and bonuses. Equity incentives. Hybrid / remote options.

Svantaggi

Poor work / life balance. Disorganized and reactive organization with many sudden shifts in strategy. Provincial mindsets are too common in this allegedly global company. To be sure, these are partly growing pains. But there’s a strong element of resisting change and regularizing processes. Certain major functions guard their privileges and way of working from the pre-commercial startup era.

Esplora altre recensioni su argenx

5,0
17 lug 2025
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Fast paced and things move forward

Svantaggi

I love it so far I have not noticed any cons

3,0
12 mag 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

*there is plenty of budget in US Commercial/MedAff org *relatively flat org structure (might be a con, dep on your style) *they pursue innovation, which is a huge PLUS in this industry *decent comp/benefits

Svantaggi

Some groups are operating without any unified strategy coming from the top.. resulting in anarchy.. which trickles down to conflicting projects or overlapping priorities.. unnecessary work, etc. The Boston office tends to be rather clique-ish and favoritism presides over merit, which contrasts with EU. argenx also lacks much of the usual infrastructure at other companies... and things still operate as if they were still a 400 person company. Culture is nonexistent unless you are in Ghent. Also, argenx does not have any employee resource groups. Zero.

Vedi recensioni per: Utile|Valutazione|Data|Tutto